Merger Notification - Announcement according to § 10 Cartel Act
HAS Healthcare Advanced Synthesis SA; 65 Equity Partners Pte. Ltd.; Cerbios-Pharma SA
BWB/Z-6890
On 21.03.2025 the Austrian Federal Competition Authority was notified of the following merger:
Planned purchase process
HAS Healthcare Advanced Synthesis SA (Biasca / Switzerland), a company of 3B Future Group (Lugano / Switzerland), intends to acquire 100% of the shares in Chemholding due SA and its subsidiary Cerbios-Pharma SA (both Lugano / Switzerland). As part of the transaction, 65 Equity Partners Pte. Ltd. (Singapore / Singapore), a wholly-owned subsidiary of Temasek Holdings (Private) Limited (Singapore / Singapore), is to acquire indirectly approx. 40% of the shares in and joint control over HAS Healthcare Advanced Synthesis. After completion of the transaction, Cerbios-Pharma SA will be indirectly jointly controlled by 3B Future Group and 65 Equity Partners Pte. Ltd. The proposed concentration concerns CDMO services.
Affected industry: manufacture of basic pharmaceutical products; manufacture of pharmaceutical preparations; research and experimental development on natural sciences and engineering.
C - MANUFACTURING C 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations, C 21.1 - Manufacture of basic pharmaceutical products, C 21.10 - Manufacture of basic pharmaceutical products, C 21.2 - Manufacture of pharmaceutical preparations, C 21.20 - Manufacture of pharmaceutical preparations, N - PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES, N 72.1 - Research and experimental development on natural sciences and engineering
Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 22.04.2025.
Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.
Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.
Non-prohibition of the merger
The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 23.04.2025 .